Skip to content

Clinical trials

Completed Phase 2 Bone Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Neoplasms Phase: Phase 2 Status: Completed Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20071
20082
20091
20102
20112
20152
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
Asan Medical Center1
AstraZeneca1
Heike E Daldrup-Link1
Hoffmann-La Roche1
InSightec1
Infinity Pharmaceuticals, Inc.1
M.D. Anderson Cancer Center1
Memorial Sloan Kettering Cancer Center1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Neoplasms13
Sarcoma8
Osteosarcoma4
Chondrosarcoma3
Rhabdomyosarcoma3
Breast Neoplasms2
Histiocytoma, Malignant Fibrous2
Liposarcoma2
Neoplasm Metastasis2
Neoplasms2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.